nsMRA, nonsteroidal mineralocorticoid receptor antagonist
- For buyers, this is not only about following the next pipeline headline
Join me Friday, July 28 for [] Episode 233: Interview with Tim Ulbrich, PharmD Pharmacist Authors Series (Summer 2023) Next up on my Pharmacist Authors Series is Tim Ulbrich, PharmD
ICH stability testing guidelines The International Council for Harmonisation (ICH) sets global standards for pharmaceutical stability testing
Semaglutide (Ozempic/Wegovy): First-line option, acts on 1 receptor (GLP-1) Tirzepatide (Mounjaro): Second-line, acts on 2 receptors (GLP-1 + GIP), effective for patients tolerant to higher semaglutide doses Retatrutide: Most advanced, acts on 3 receptors (GLP-1 + GIP + GCGR), typically reserved for patients who have developed tolerance to tirzepatide Category: Weight Loss Related Products Medication Features Once-weekly injection Weight loss injection by Eli Lilly Active ingredient: Tirzepatide Trials show ~20% body weight loss Available equivalent: Wegovy Mounjaro is a once-weekly weight loss injection containing Tirzepatide and is now licensed for weight loss in the UK